BGE-102
potent, orally available, brain-penetrant small-molecule NLRP3 inhibitor being developed for cardiovascular risk and retinal diseases
What it does
potent, orally available, brain-penetrant small-molecule NLRP3 inhibitor being developed for cardiovascular risk and retinal diseases
- treat cardiometabolic disease
- target biology of human aging
- develop therapies for obesity
- develop therapies for cardiovascular risk and retinal diseases
- identify molecular mediators of aging and disease
- develop therapeutic product candidates for metabolic diseases
- address key pathways involved in metabolic aging
- find pathways impacting human lifespan and healthspan
- Category
- Drug discovery and biotech
- Built for
- Healthcare and life sciences, Media and entertainment, Consumer
- Users
- patients with metabolic diseases
- Public API
- Not offered
Not yet disclosed: deployment options, platforms, languages and support channels.
Pricing
Pricing isn't published
BioAge Labs, Inc. doesn't list prices publicly. Ask them for a quote.
Security and compliance
No security details published yet
BioAge Labs, Inc. hasn't published certifications or security practices for BGE-102 that we could find. Ask their team for audit reports.
Reviews
No reviews yet
Reviews come from people who use BGE-102 at work. Share how your team uses it to help other buyers decide.
Alternatives
ITO™ Platform
by 1910
Cloud-based end-to-end platform integrating massive multimodal data, frontier AI models, and high-throughput lab automation to deliver small and large molecule drug candidates f...
AI Agents
by Enjamb Labs
Agentic orchestration that coordinates specialized agents across evidence, trial design, statistical programming, and regulatory writing inside one auditable workspace.
Integrations
by Invert
Pre-built connectivity to every instrument, historian, ELN/LIMS, and enterprise data store that matters in bioprocess.
Numerion Labs Drug Discovery Platform
by Numerion Labs
AI-driven drug-hunting superplatform that uses a universal chemistry foundation model (COSMOS), a hyper-scalable enumerator (APEX), and expert optimization algorithms (EXPO) to...
Scientific evidence synthesis service delivering structured evidence packages for target, indication, biomarker, and trial design decisions on named drug assets.
Precision medicine
by Parallel Bio
Maps of human biology for personalized insights and patient stratification in ways never previously possible.
Is this your product?
Claim it to keep details accurate and submit evidence for the next ranking review.
Claim BGE-102